Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study
T Huwyler(University of Geneva), Angela Huttner(University Hospital of Geneva), L. Lenggenhager(University of Geneva), Pierre Lescuyer(University Hospital of Geneva), İlker Uçkay(University of Zurich), Stephan Harbarth(University Hospital of Geneva), Abderrahim Karmime(SIB Swiss Institute of Bioinformatics), Benedikt Huttner(World Health Organization), Severine Hughes(University Hospital of Geneva), Kuntheavy Ing Lorenzini(University Hospital of Geneva), Mohamed Abbas, Elodie von Dach(University Hospital of Geneva)
Cited by 140
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
|Diabetes/Metabolism Research and Reviews|2023|283